Current Controlled Trials in Cardiovascular Medicine (Mar 2001)

Tamoxifen may reduce CHD risk via inflammatory mediators

  • Lyford Joanna,
  • Cushman M,
  • Costantino JP,
  • Tracy RP,
  • Song K,
  • Buckley L,
  • Roberts JD,
  • Krag DN

DOI
https://doi.org/10.1186/cvm-2001-72051
Journal volume & issue
Vol. 2
pp. 72051 – 261

Abstract

Read online

No abstracts available.

Keywords